期刊文献+

Toll样受体4在宫颈细胞系和宫颈上皮病变中的表达及与HPV16感染的关系 被引量:5

Expression of Toll-like receptor 4 in cervical cell lines and cervical lesions and its relation to HPV16 infection
下载PDF
导出
摘要 目的:检测Toll样受体4(Toll-like receptor 4,TLR4)在宫颈细胞系和宫颈病变组织中的表达,探讨TLR4在宫颈病变进展中的作用及与人乳头状瘤病毒(human papillomavirus 16,HPV16)感染的关系。方法:用RT-PCR检测H8,SiHa,Caski细胞中HPV16 E6基因的mRNA含量;Western免疫印迹测定3种细胞系中TLR4蛋白含量;免疫组织化学检测127例慢性宫颈炎、宫颈上皮内瘤变(cervical intra-epithelial neoplasia,CIN)以及宫颈鳞癌病变组织石蜡切片中TLR4蛋白的表达。抽提石蜡组织总DNA,用PCR方法检测组织中HPV16的感染情况。结果:Caski和SiHa细胞中HPV16 E6基因mRNA含量和TLR4蛋白表达明显高于H8正常对照(P<0.05),且Caski细胞中HPV16 E6基因mRNA含量和TLR4蛋白表达也显著高于SiHa细胞(P<0.05);TLR4在慢性子宫颈炎,CIN和宫颈鳞癌组织的表达分别为32.0%,59.4%和77.8%,随着宫颈上皮病变加重TLR4表达增强(P<0.01),并且与宫颈癌分化程度有关(P<0.01);HPV16在宫颈病变组织中的表达随着病理分级逐渐增高,在慢性子宫颈炎、CIN和宫颈鳞癌组织中分别为8.0%,48.4%和81.0%(P<0.01);在CIN和宫颈癌组织中TLR4与HPV16相关(r=0.303,P<0.05;r=0.633,P<0.05)。结论:HPV16感染可以上调TLR4在宫颈上皮病变中的表达,TLR4与HPV16共同作用对宫颈上皮从炎症发展到CIN至宫颈癌过程中发挥重要作用。 Objective:To explore the relation between human papillomavirus (HPV16) infection and expression of Toll-like receptor 4 (TLR4) in cervical cell lines and cervical lesion tissues and to investigate the effect of TLR4 on cervical cancer progression.Methods:Expression of HPV16 E6 mRNA was detected by RT-PCR. Western blot and immunohistochemistry were used to detect the expression of TLR4 in H8, SiHa, Caski cell lines and formalin-ifxed and paraffn-embeded cervical tissue specimens with cervicitis, cervical intra-epithelial neoplasia (CIN) and cervical squamous cell carcinama (CSCC). DNA was extracted from paraffn-embedded cervical cancer tissues and HPV16 genes were detected. Results:The differentiation expression of HPV16 E6 mRNA and TLR4 in SiHa and Caski was signiifcantly higher than that of normal cervical cell H8 (P0.05). hTe expression of TLR4 was signiifcantly correlated with HPV16 infection in CIN and CSCC (r=0.303, P Conclusion:High expression of TLR4 may play important roles in the development and progression of CIN and CSCC, and the expression of TLR4 can be up-regulated by HPV16 infection.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2013年第11期1110-1116,共7页 Journal of Central South University :Medical Science
基金 新疆自然科学基金(2012211B10)~~
关键词 宫颈细胞系 子宫颈病变 TOLL样受体4 人乳头状瘤病毒16 cervical cell lines cervical lesion Toll-like receptor 4 HPV16
  • 相关文献

参考文献20

  • 1Dunne EE Sternberg M, Markowitz LE, et al. Human papillomavirus (HPV) 6,11,16, and 18 prevalence among females in the United States- National Health And Nutrition Examination Survey, 2003--2006: opportunity to measure HPV vaccine impact[J]. Infect Dis, 2011, 204(4): 562.
  • 2Maclag PC, Schlcht NF, Souza PS, et al. Major histocompatibility complex and human papiUomavirus infection in Brazilian women [J]. Cancer Epidemiol Biomakers Prev, 2000, 9(11): 1183-1191.
  • 3Akira S, Hemmi H. Recognition of pathogen-associated molecular patens by TLR family [J]. Immunol Lett, 2003, 85 (2): 85-95.
  • 4Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitates evasion of immune surveillance [J]. Cancer Res, 2005, 65(12): 5009- 5014.
  • 5Szczepanski MJ, Czystowska M, Szajnik M, et al. Triggering of Toll- like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack [J]. Cancer Res, 2009, 69(7): 3105-3113.
  • 6Kelly MG, Alvero AB, Chen R, et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer [J]. Cancer Res, 2006, 66 (7): 3859-3868.
  • 7Doan HQ, Bowen KA, Jackson LA, et al. Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells [J]. Anticancer Res, 2009, 29(7): 2473-2478.
  • 8Hsu RY, Chan CH, Spicer JD, et al. LPS-induced TLR4 signaling in human colorectal cancer cells increases betal integrin-mediated cell adhesion and liver metastasis [J]. Cancer Res, 2011,71 (5): 1989-1998.
  • 9Gokdeniz R, Ozen S, Mizrak B, et al. GnRH agonist decreases endothelial nitric oxide synthase (eNOS) expression in leiomyoma [J]. lntJ Gynaecol Obstet, 2000, 70(3): 347-352.
  • 10Lee JW, Choi J J, Seo ES, et al. Increased Toll-lik e receptor 9 expression in cervical neoplasia [J]. Mol Carcinogen, 2007, 46(11):941-947.

二级参考文献33

共引文献14

同被引文献41

  • 1曾治民,何静,刘安文.Toll样受体信号传导与炎症相关肿瘤的关系[J].中国癌症杂志,2011,21(6):489-494. 被引量:17
  • 2Peghini BC, Abdalla DR,Barcelos AC, et al. Local cytokine pro- files of patients with cervical intraepithelial and invasive neopla- sia[J]. Hum Immunol, 2012, 73(9):920-926.
  • 3Bagarazzi ML, Yan J, Morrow MP, et al. Immunotherapy a gainst HPV16/18 generates potent TH1 and cytotoxie cellular immune responses[J]. Sci Transl Med, 2012, 4 (155): 155ra138.
  • 4Chauss6 AM, Gr6pinet O, Bottreau E, et al. Expression of Tolllike receptor 4 and downstream effectors in selected cecal celI subpopulations of chicks resistant or susceptible to Salmo- nella carrier state[J]. Infect Immun, 2011, 79(8) : 3445.
  • 5Duarte FV, Gomes AP, Teodoro JS, et al. Dibenzofuran in duced mitochondrial dysfunction: Interaction with ANT carrier [J]. Toxicology in Vitro, 2013, 27(8) : 2160 2168.
  • 6Cirri P,Chiarugi P. Tumors and their stroma: Mitochondria at the crossroad[J]. Cell Cycle,2013, 12(2) : 204 205.
  • 7OgemboRK, GonaPN, SeymourA], etal. PrevalenceofHu?man Papillomavirus Genotypes among African Women with Normal Cervical Cytology and Neoplasia: A Systematic Review and Meta-Analysis[J]. PLoS One, 2015, 10(4) :e0122488.
  • 8Scott ME, Ma Y, Farhat S, et al. Expression of nucleic acid?sensing Toll-like receptors predicts HPV16 clearance associat?ed with an E6 - directed cell-mediated response[J]. Int J Canc?er, 2015, 136(10) :2402-2408.
  • 9Yu SL, Chan PK, Wong CK, et al. Antagonist-mediated down?regulation of Toll- like receptors increases the prevalence of human papilloma virus infection in systemic lupus erythematosus[J]. Arthritis Res Ther, 2012, 14(2) :R80.
  • 10Amador-Molina A, Hernandez- Valencia JF, Larnoyi E, et al. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response[J]. Viruses, 2013, 5(11) :2624-2642.

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部